UPDATE: Morgan Stanley Reiterates Overweight Rating, Removes PT on Vitamin Shoppe on Favorable Risk/Reward

In a report published Friday, Morgan Stanley analyst Simeon Gutman reiterated an Overweight rating on

, but removed the $49.00 price target. In the report, Morgan Stanley noted, “GNC and VSI have surged recently on the back of consolidation/takeout hopes. We have no knowledge of any deal.Since August 7, GNC is up 20% while VSI has risen 15%.This was helped by yesterday's 5% increase in both names.” Vitamin Shoppe closed on Thursday at $45.44.